PATRIOT Trial: Randomized phase II study of prostate stereotactic body radiotherapy comparing 11 versus 29 days overall treatment time

被引：6
|
作者：
Quon, Harvey Charles
Ong, Aldrich
Cheung, Patrick
Chu, William
Chung, Hans T.
Vesprini, Danny
Chowdhury, Amit
Panjwani, Dilip
Pang, Geordi
Korol, Renee
Davidson, Melanie
Ravi, Ananth
McCurdy, Boyd
Zhang, Liying
Bucher, Oliver
Mamedov, Alexandre
Deabreu, Andrea
Lylyk, Elizabeth
Loblaw, Andrew
机构：
[1] CancerCare Manitoba, Winnipeg, MB, Canada
[2] Sunnybrook Hlth Sci Ctr, Odette Canc Ctr, Toronto, ON M4N 3M5, Canada
[3] BC Canc Agcy, Abbotsford, BC, Canada
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 07期
关键词：
D O I：
10.1200/jco.2015.33.7_suppl.6
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Comparing conVEntional RadioTherapy with stereotactIC body radiotherapy in patients with spinAL metastases: study protocol for an randomized controlled trial following the cohort multiple randomized controlled trial design
    van der Velden, Joanne M.
    Verkooijen, Helena M.
    Seravalli, Enrica
    Hes, Jochem
    Gerlich, A. Sophie
    Kasperts, Nicolien
    Eppinga, Wietse S. C.
    Verlaan, Jorrit-Jan
    van Vulpen, Marco
    BMC CANCER, 2016, 16
  • [32] Magnetic resonance imaging-guided stereotactic body radiotherapy for prostate cancer (mirage): a phase iii randomized trial
    Ting Martin Ma
    James M. Lamb
    Maria Casado
    Xiaoyan Wang
    T. Vincent Basehart
    Yingli Yang
    Daniel Low
    Ke Sheng
    Nzhde Agazaryan
    Nicholas G. Nickols
    Minsong Cao
    Michael L. Steinberg
    Amar U. Kishan
    BMC Cancer, 21
  • [33] Magnetic resonance imaging-guided stereotactic body radiotherapy for prostate cancer (mirage): a phase iii randomized trial
    Ma, Ting Martin
    Lamb, James M.
    Casado, Maria
    Wang, Xiaoyan
    Basehart, T. Vincent
    Yang, Yingli
    Low, Daniel
    Sheng, Ke
    Agazaryan, Nzhde
    Nickols, Nicholas G.
    Cao, Minsong
    Steinberg, Michael L.
    Kishan, Amar U.
    BMC CANCER, 2021, 21 (01)
  • [34] Randomized phase II study of stereotactic body radiotherapy and interleukin-2 versus interleukin-2 in patients with metastatic melanoma
    Curti, Brendan
    Crittenden, Marka
    Seung, Steven K.
    Fountain, Christopher B.
    Payne, Roxanne
    Chang, ShuChing
    Fleser, Jessica
    Phillips, Kimberly
    Malkasian, Ian
    Dobrunick, Lyn B.
    Urba, Walter J.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 (01)
  • [35] Quality of Life Following Stereotactic Body Radiotherapy Versus Three-Dimensional Conformal Radiotherapy for Vertebral Metastases: Secondary Analysis of an Exploratory Phase II Randomized Trial
    Sprave, Tanja
    Verma, Vivek
    Foerster, Robert
    Schlampp, Ingmar
    Bruckner, Thomas
    Bostel, Tilman
    El Shafie, Rami Ateayh
    Nicolay, Nils Henrik
    Debus, Juergen
    Rief, Harald
    ANTICANCER RESEARCH, 2018, 38 (08) : 4961 - 4968
  • [36] Stereotactic ablative radiotherapy for comprehensive treatment of oligometastatic tumors (SABR-COMET): Study protocol for a randomized phase II trial
    Palma, David A.
    Haasbeek, Cornelis J. A.
    Rodrigues, George B.
    Dahele, Max
    Lock, Michael
    Yaremko, Brian
    Olson, Robert
    Liu, Mitchell
    Panarotto, Jason
    Griffioen, Gwendolyn H. M. J.
    Gaede, Stewart
    Slotman, Ben
    Senan, Suresh
    BMC CANCER, 2012, 12
  • [37] Stereotactic ablative radiotherapy for comprehensive treatment of oligometastatic tumors (SABR-COMET): Study protocol for a randomized phase II trial
    David A Palma
    Cornelis J A Haasbeek
    George B Rodrigues
    Max Dahele
    Michael Lock
    Brian Yaremko
    Robert Olson
    Mitchell Liu
    Jason Panarotto
    GwendolynHMJ Griffioen
    Stewart Gaede
    Ben Slotman
    Suresh Senan
    BMC Cancer, 12
  • [38] A Randomized Phase II Trial of Prostate Boost Irradiation With Stereotactic Body Radiotherapy (SBRT) or Conventional Fractionation (CF) External Beam Radiotherapy (EBRT) in Locally Advanced Prostate Cancer: The PBS Trial (NCT03380806)
    Isfahanian, Naghmeh
    Lukka, Himanshu
    Dayes, Ian
    Quan, Kimmen
    Schnarr, Kara Lynne
    Douvi, Georgia
    Goldberg, Mira
    Wright, Jim
    Swaminath, Anand
    Chow, Tom
    Diamond, Kevin
    Cutz, Jean Claude
    Kavsak, Peter
    Thabane, Lehana
    Tsakiridis, Theodoros
    CLINICAL GENITOURINARY CANCER, 2020, 18 (04) : E410 - E415
  • [39] MR-guided adaptive versus ITV-based stereotactic body radiotherapy for hepatic metastases (MAESTRO): a randomized controlled phase II trial
    P. Hoegen
    K. S. Zhang
    E. Tonndorf-Martini
    F. Weykamp
    S. Regnery
    P. Naumann
    K. Lang
    J. Ristau
    S. A. Körber
    C. Dreher
    C. Buchele
    C. Rippke
    C. K. Renkamp
    K. M. Paul
    L. König
    C. Büsch
    J. Krisam
    O. Sedlaczek
    H.-P. Schlemmer
    M. Niyazi
    S. Corradini
    J. Debus
    S. Klüter
    J. Hörner-Rieber
    Radiation Oncology, 17
  • [40] MR-guided adaptive versus ITV-based stereotactic body radiotherapy for hepatic metastases (MAESTRO): a randomized controlled phase II trial
    Hoegen, P.
    Zhang, K. S.
    Tonndorf-Martini, E.
    Weykamp, F.
    Regnery, S.
    Naumann, P.
    Lang, K.
    Ristau, J.
    Koerber, S. A.
    Dreher, C.
    Buchele, C.
    Rippke, C.
    Renkamp, C. K.
    Paul, K. M.
    Koenig, L.
    Buesch, C.
    Krisam, J.
    Sedlaczek, O.
    Schlemmer, H-P
    Niyazi, M.
    Corradini, S.
    Debus, J.
    Klueter, S.
    Hoerner-Rieber, J.
    RADIATION ONCOLOGY, 2022, 17 (01)
12345